风湿消息
2024年8月21日至25日,备受瞩目的第26届亚太风湿病联盟年会(APLAR 2024)在新加坡隆重举行。共计2000余名来自世界各地的从事风湿病学、免疫学以及相关领域的专家学者齐聚Suntec会议中心,共同探讨全球风湿免疫领域的最新研究和进展。
此外,该团队再次被批准为亚太风湿病中心(COE),成为亚太地区连续获得授牌的三个中心之一,将作为亚太风湿病研究和交流中心,承担亚太地区风湿病青年医生的培训等任务。
APLAR 2024为全球风湿免疫学领域的专家学者提供了交流合作的平台,众家云集,各抒己见。秉持科学研究与临床应用相结合的理念,致力于推动风湿免疫学理论与治疗的创新发展,将前沿的学术成果尽快转化到临床治疗中,更好的为风湿免疫患者解除病痛。
闭幕式典礼(视频)
姓名 |
投稿题目 |
李英妮 |
Reliable detection of IL-2 in CD3+ T cells to assess |
李嘉辰 |
Baricitinib for Takayasu arteritis refractory to TNF-α inhibitors: a prospective pilot open-label study |
金善钊 |
Single-Cell Profiling Changes Associated with Drug Resistance and Disease Progression to Methotrexate and Anti-TNF Therapies in RheumatoiSingle-Cell Profiling Changes Associated with Drug Resistance and Disease Progression to Methotrexate and Anti-TNF Therapies in Rheumatoid Arthritisd Arthritis |
曾星月, 李雪 |
Systemic lupus erythematosus presenting solely as hemolytic anemia: a distinct subgroup characterized by unique mechanisms, disease severity, and prognosis |
徐丽玲 |
The role of growth arrest specific protein 6 in antiphospholipid syndrome |
王乃迪 |
Analysis |
赵亚云 |
Effect of rituximab treatment for renal involvement in Sjögren's syndrome |
陈辰 |
Unsupervised machine learning improves clinical stratification and prognostic evaluation for antiphospholipid syndrome: A large cohort study from China |
莫万星 |
The Role of Peripheral B-Cell Subsets in Idiopathic Inflammatory Myopathies: Implications for Pathogenesis and Therapeutic Targets |
唐蕴荻 |
Soluble receptor LILRA3 as a novel regulator of thrombosis by inducing neutrophil-mediated NETosis in antiphospholipid syndrome (APS) |
赵亮 |
Risk Factors and Prognostic Outcomes of Patients with Idiopathic Inflammatory Myopathy complicated with infection |
王平 |
MDSCs are important osteoclast precursors primed by B cells in rheumatoid arthritis |
李雪 |
Low-dose IL-2 Therapy for Neuromyelitis Optica |
李浩 |
Impact of long COVID on patients with Sjögren’s syndrome and risk factors: a longitudinal study in China |
韩奕芃 |
Immune profiling of T helper cell subsets in SSA/SSB double negative Sjögren’s syndrome patients in China |
魏超楠 |
Combination of scavenger receptor-A with anti-cyclic citrullinated peptide antibody for the diagnosis of rheumatoid arthritis |
程功 |
A disease typing study of Sjögren's syndrome based on machine learning |
许曦 |
Serum IgG4 level is associated with disease activity of ANCA-associated vasculitis |
邢晓燕 |
Treatment of Active Dermatomyositis by Tofacitinib: A Prospective Cohort Pilot Study |
王文琼 |
The effect of dickopf-1 on bone erosion and synovitis in inflammatory arthritis |
王文琼 |
The immune and growth characteristics of children born to mothers with systemic lupus erythematosus |
刘庆红 |
Risk factors for vascular occlusion in patients with eosinophilic granulomatosis with polyangiitis |
孙晓麟 |
Single-cell multi-omics analysis revealing immune features of inactivated COVID-19 vaccination in systemic lupus erythematosus patients |
徐浩杰 |
A case on the efficacy of upadacitinib in treating Sjögren’s syndrome complicated with atopic dermatitis |
苗苗 |
Impaired Skin-homing CLA+ Regulatory T cell: an Indicator of Disease Severity in Idiopathic Inflammatory Myopathies |
梁人戈 |
Elevated Expression of Mer Receptor Tyrosine Kinase of NK cells in Patients with Systemic Lupus Erythematosus |
裴文文 |
Axl Receptor Tyrosine Kinase Regulates Innate Immune in Diffuse Alveolar Hemorrhage in Murine Lupus |
姚然然 梁人戈 |
Coronavirus Disease 2019 and Psoriatic Arthritis: Features and Connections |
饶佩诗 |
A novel P2X7 receptor antagonist EVT-401 inhibits inflammatory arthritis by regulating fibroblast-like synoviocyte |
朱丹雪 |
Deficiency of circulating CLA+Tregs and the therapeutic potential in rheumatoid arthritis |
宋子怡 |
Ruxolitinib in adult macrophage activation syndrome:A single-centre case series of eight patients |
王一帆 |
Exploring the role of T follicular helper cells in immune-related adverse events and the therapeutic potential of low-dose IL-2 |
曹世雄 |
Serum sCD25 is an indicator for Rheumatoid Arthritis-Associated Interstitial Lung Disease |